72.11.Z - Research and experimental development on biotechnology
18.20.Z - Reproduction of recorded media
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
62.03.Z - Computer facilities management activities
62.09.Z - Other information technology and computer service activities
63.11.Z - Data processing, hosting and related activities
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0 | -0 | -0 | -6,7 |
Gross profit (loss) | 0,6 | 0 | 0 | 28,5 |
EBITDA | -0 | -0 | -0 | -6,7 |
Short time liabilities | 0,1 | 0 | 0 | -∞ |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 1,3 | 1 | 1 | 1,7 |
Operating profit (EBIT) | -0 | -0 | -0 | -6,7 |
Assets | 1,3 | 1 | 1 | 2,1 |
Net profit (loss) | 0,5 | 0 | 0 | 28,5 |
Cash | 0,6 | 0 | 0 | 7,9 |
Liabilities and provisions for liabilities | 0,1 | 0 | 0 | -∞ |
Net income from sale | 0 | 0 | 0 | 0 |
Working assets | 0,6 | 0,2 | 0,2 | 8,9 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 40,6 | 0,7 | 0,9 | 0,2 |
Equity capital to total assets | 95,1 | 100 | 99,6 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 0 | 2 147 483 648 | 2 147 483 648 |
Current financial liquidity indicator | 9.051676750183105 | 59.44696044921875 | 50,3 | |
Net dept to EBITDA | 2126.043701171875 | 54.17314910888672 | 54.80915069580078 | 0,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane